Physician profile
Duncan P Yoder
NPI 1013142025
$3,666.94
in general payments reported to CMS, 2019-2025
14 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $219 · 2021: $99.99 · 2022: $340 · 2023: $595 · 2024: $1,735 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,402 · Food and Beverage: $1,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,401.66 |
| Food and Beverage | $1,093.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organox Ltd | $1,325.54 | 2024 | Metra |
| W. L. Gore & Associates, INC. | $437.69 | 2019-2024 | Gore Dryseal Flex Introducer Sheath |
| Boston Scientific Corporation | $375.73 | 2020-2025 | General - Vascular Intervention |
| Bard Peripheral Vascular, INC. | $268.77 | 2019-2024 | Venovo |
| Medtronic, INC. | $264.57 | 2022-2023 | Endurant Iis |
| Medtronic Vascular, INC. | $204.23 | 2019-2020 | |
| Intuitive Surgical, INC. | $181.08 | 2023 | Da Vinci Surgical System |
| Biocomposites INC | $131.40 | 2023 | Stimulan |
| Philips North America LLC | $99.99 | 2021 | |
| Endologix LLC | $97.88 | 2022 | |
| Janssen Pharmaceuticals, INC | $97.31 | 2023 | Xarelto |
| Bolton Medical INC | $83.05 | 2022 | |
| Ge Healthcare | $80.06 | 2023 | |
| Coopersurgical, INC. | $19.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duncan Yoder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.